tiprankstipranks
ProMIS Neurosciences (PMN)
NASDAQ:PMN
US Market

ProMIS Neurosciences (PMN) Financial Statements

Compare
291 Followers

ProMIS Neurosciences Financial Overview

ProMIS Neurosciences's market cap is currently $31.73M. The company's EPS TTM is $-4.11; its P/E ratio is -0.30; ProMIS Neurosciences is scheduled to report earnings on March 25, 2026, and the estimated EPS forecast is $-1.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00-
Gross ProfitC$ 0.00C$ 0.00C$ -10.44MC$ 0.00-
Operating IncomeC$ -40.17BC$ -16.83MC$ -18.90MC$ -23.38M-
EBITDAC$ -40.17BC$ 2.86MC$ -17.81MC$ -17.77MC$ -9.33M
Net IncomeC$ -39.72BC$ 2.78MC$ -17.51MC$ -18.06M-
Balance Sheet
Cash & Short-Term InvestmentsC$ 6.15BC$ 13.32MC$ 12.63MC$ 8.01MC$ 21.48M
Total AssetsC$ 9.18BC$ 18.91MC$ 13.62MC$ 9.38MC$ 22.44M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 4.94M
Net DebtC$ -6.12BC$ -13.29MC$ -12.60MC$ -7.96MC$ -16.49M
Total LiabilitiesC$ 10.44BC$ 2.42MC$ 9.87MC$ 11.20MC$ 15.28M
Stockholders' EquityC$ -1.26BC$ 16.49MC$ 3.75MC$ -1.82MC$ 7.16M
Cash Flow
Free Cash FlowC$ -28.12BC$ -27.18MC$ -10.84MC$ -17.04MC$ -9.45M
Operating Cash FlowC$ -28.12BC$ -27.18MC$ -10.84MC$ -17.03MC$ -9.44M
Investing Cash FlowC$ -702.00KC$ -693.00C$ -1.35KC$ -1.98KC$ 95.93K
Financing Cash FlowC$ 20.94BC$ 27.88MC$ 17.75MC$ 6.49MC$ 25.63M
Currency in CAD

ProMIS Neurosciences Earnings and Revenue History

ProMIS Neurosciences Debt to Assets

ProMIS Neurosciences Cash Flow

ProMIS Neurosciences Forecast EPS vs Actual EPS